Wolverine Trading, LLC Exelixis, Inc. Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 62,194 shares of EXEL stock, worth $2.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,194

Previous 51,500 20.77%

Holding current value

$2.1 Million

Previous $1.16 Million 39.41%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$21.96 - $27.6 $1.37 Million - $1.72 Million	62,194 New	62,194 $1.61 Million
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $332,615 - $441,707	-19,072 Reduced 65.19%	10,186 $212,000
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $285,389 - $394,211	18,017 Added 160.28%	29,258 $545,000
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $320,669 - $415,887	-19,673 Reduced 63.64%	11,241 $232,000
Q2 2021 Aug 06, 2021	BUY	$17.95 - $25.56 $350,563 - $499,186	19,530 Added 171.56%	30,914 $555,000
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $69,001 - $84,764	-3,361 Reduced 22.79%	11,384 $250,000
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $9,139 - $12,325	497 Added 3.49%	14,745 $298,000
Q3 2020 Nov 13, 2020	SELL	$20.67 - $26.94 $324,353 - $422,742	-15,692 Reduced 52.41%	14,248 $349,000
Q4 2019 Feb 12, 2020	SELL	$15.15 - $18.89 $8,377 - $10,446	-553 Reduced 1.81%	29,940 $531,000
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $130,991 - $167,813	-7,409 Reduced 19.55%	30,493 $549,000
Q2 2019 Aug 20, 2019	BUY	$18.93 - $24.75 $240,429 - $314,349	12,701 Added 50.4%	37,902 $810,000
Q1 2019 May 15, 2019	SELL	$19.6 - $24.76 $179,888 - $227,247	-9,178 Reduced 26.7%	25,201 $600,000
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $111,397 - $177,909	-8,161 Reduced 19.18%	34,379 $668,000
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $240,954 - $340,099	15,183 Added 55.5%	42,540 $754,000
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $382,729 - $551,027	17,279 Added 171.45%	27,357 $606,000
Q4 2017 Feb 14, 2018	SELL	$24.23 - $30.93 $24,593 - $31,393	-1,015 Reduced 9.15%	10,078 $306,000
Q3 2017 Nov 15, 2017	BUY	$23.35 - $29.24 $259,021 - $324,359	11,093	11,093 $269,000

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account

Wolverine Trading, LLC Exelixis, Inc. Transaction History